Australia's most trusted
source of pharma news
Wednesday, 04 March 2026
Posted 4 March 2026 AM
Fresh from an historic reimbursement win in Australia, BMS has taken the fight over the ditch, with a new report spotlighting the agonising wait times for access to innovative medicines in New Zealand.
The most damning statistics reveal delays of seven to 10 years between regulatory approval from Medsafe and funding through Pharmac, for many medicines. This compares to six to 18 months in Australia and the United Kingdom.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.